Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study
With everyone online selling GLP-1s, Spencer Nadolsky, the medical director at Weight Watchers, wrote on X earlier this year, What will you do to be different? In another post, he wrote: Youre going to have to come up with a different value proposition beyond access to these medicines. Hims executives appear to be cashing out while they can
How to Tell if Your Medication Has Gone Bad Sometimes, your pen will give you a visual warning that it is no longer safe to use
Schunkert EM, Shah PN, Divito SJ
Professor Patricia Grigson, chair of the Department of Neural and Behavioral Sciences, said: Our results are very promising as GLP-1R agonist treatment appears to be highly protective, but more research is needed to establish a causal relationship between the use of these drugs and decreased risk for severe COVID-19 outcomes in patients with type 2 diabetes. People with diabetes are at a greater risk of severe COVID-19 outcomes, with a recent study highlighting that almost a third of COVID-19-related deaths in England were made up of people with type 2 diabetes